These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8146873)

  • 21. Snake venomics of the Siamese Russell's viper (Daboia russelli siamensis) -- relation to pharmacological activities.
    Risch M; Georgieva D; von Bergen M; Jehmlich N; Genov N; Arni RK; Betzel C
    J Proteomics; 2009 Mar; 72(2):256-69. PubMed ID: 19457351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological activities of Vipegrin, an anti-adhesive Kunitz-type serine proteinase inhibitor purified from Russell's viper venom.
    Bhattacharya N; Kolvekar N; Mondal S; Sarkar A; Chakrabarty D
    Toxicon; 2023 Aug; 232():107213. PubMed ID: 37419286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and amino-acid sequence of a nerve growth factor from the venom of Vipera russelli russelli.
    Koyama J; Inoue S; Ikeda K; Hayashi K
    Biochim Biophys Acta; 1992 Dec; 1160(3):287-92. PubMed ID: 1477101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary sequence determination of the most basic myonecrotic phospholipase A2 from the venom of Vipera russelli.
    Gowda VT; Schmidt J; Middlebrook JL
    Toxicon; 1994 Jun; 32(6):665-73. PubMed ID: 7940574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eight cases of acute renal failure from Vipera russelli formosensis venom after administration of antivenom.
    Chou TS; Lin TJ; Kuo MC; Mee-Sun T; Hung DZ; Tsai JL
    Vet Hum Toxicol; 2002 Oct; 44(5):278-82. PubMed ID: 12361111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and pharmacological characterization of a toxic fraction and its cytotoxin-like component isolated from Russell's viper (Daboia russelii russelii) venom.
    Thakur R; Chattopadhyay P; Mukherjee AK
    Comp Biochem Physiol C Toxicol Pharmacol; 2015 Feb; 168():55-65. PubMed ID: 25500420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissociation of catalytic activity and neurotoxicity of a basic phospholipase A2 from Russell's viper (Vipera russelli) venom.
    Jayanthi GP; Kasturi S; Gowda TV
    Toxicon; 1989; 27(8):875-85. PubMed ID: 2781586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotoxicity in Sri Lankan Russell's Viper (Daboia russelii) Envenoming is Primarily due to U1-viperitoxin-Dr1a, a Pre-Synaptic Neurotoxin.
    Silva A; Kuruppu S; Othman I; Goode RJ; Hodgson WC; Isbister GK
    Neurotox Res; 2017 Jan; 31(1):11-19. PubMed ID: 27401825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and pharmacological properties of a new thrombin-like serine protease (Russelobin) from the venom of Russell's Viper (Daboia russelii russelii) and assessment of its therapeutic potential.
    Mukherjee AK; Mackessy SP
    Biochim Biophys Acta; 2013 Jun; 1830(6):3476-88. PubMed ID: 23416064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and pharmacological properties of phospholipases A2 from Vipera russelli (Russell's viper) snake venom.
    Huang HC; Lee CY
    Toxicon; 1984; 22(2):207-17. PubMed ID: 6729839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences between the venoms of two sub-species of Russell's viper: Vipera russelli pulchella and Vipera russelli siamensis.
    Woodhams BJ; Wilson SE; Xin BC; Hutton RA
    Toxicon; 1990; 28(4):427-33. PubMed ID: 2349584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of local effects of Indian Daboia/Vipera russelli venom by the methanolic extract of grape (Vitis vinifera L.) seeds.
    Mahadeswaraswamy YH; Devaraja S; Kumar MS; Goutham YN; Kemparaju K
    Indian J Biochem Biophys; 2009 Apr; 46(2):154-60. PubMed ID: 19517992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Snake venom proteinase inhibitors. I. Isolation and properties of two inhibitors of kallikrein, trypsin, plasmin, and alpha-chymotrypsin from the venom of Russell's viper (Vipera russelli).
    Takahashi H; Iwanaga S; Suzuki T
    J Biochem; 1974 Oct; 76(4):709-19. PubMed ID: 4279913
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of a pro-angiogenic, novel peptide from Russell's viper (Daboia russelii russelii) venom.
    Mukherjee AK; Chatterjee S; Majumder S; Saikia D; Thakur R; Chatterjee A
    Toxicon; 2014 Jan; 77():26-31. PubMed ID: 24184153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of antithrombin III and antivenom on procoagulant activity of Russell's viper venom in a whole blood model.
    Clemens R; Lorenz R; Pukrittayakamee S; Punpoowang B; Vanijanonta S; Charoenlarp P
    Southeast Asian J Trop Med Public Health; 1995 Mar; 26(1):143-8. PubMed ID: 8525402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geographical variation in India in the composition and lethal potency of Russell's viper (Vipera russelli) venom.
    Jayanthi GP; Gowda TV
    Toxicon; 1988; 26(3):257-64. PubMed ID: 3293265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. beta-RTX. A receptor-active protein from Russell's viper (Vipera russelli russelli) venom.
    Bevan P; Hiestand P
    J Biol Chem; 1983 Apr; 258(8):5319-26. PubMed ID: 6300128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and pharmacological comparison of daboiatoxin from Daboia russelli siamensis with viperotoxin F and vipoxin from other vipers.
    Gopalan G; Thwin MM; Gopalakrishnakone P; Swaminathan K
    Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):722-9. PubMed ID: 17505111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Venom of Indian monocellate cobra and Russell's viper show anticancer activity in experimental models.
    Debnath A; Chatterjee U; Das M; Vedasiromoni JR; Gomes A
    J Ethnopharmacol; 2007 May; 111(3):681-4. PubMed ID: 17258413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unraveling the Proteome Composition and Immuno-profiling of Western India Russell's Viper Venom for In-Depth Understanding of Its Pharmacological Properties, Clinical Manifestations, and Effective Antivenom Treatment.
    Kalita B; Patra A; Mukherjee AK
    J Proteome Res; 2017 Feb; 16(2):583-598. PubMed ID: 27936776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.